tetano
Editor, Senior Moderator
Laryngoscope. 2020 Mar 26. doi: 10.1002/lary.28672. [Epub ahead of print]
COVID-19 and the otolaryngologist - preliminary evidence-based review.
Vukkadala N[SUP]1[/SUP], Qian ZJ[SUP]1[/SUP], Holsinger FC[SUP]1[/SUP], Patel ZM[SUP]1[/SUP], Rosenthal E[SUP]1[/SUP].
Author information
Abstract
The SARS-CoV-2 virus which causes coronavirus disease 2019 (COVID-19) has rapidly swept across the world since its identification in December 2019. Otolaryngologists are at unique risk due to the close contact with mucus membranes of the upper respiratory tract and have been among the most affected healthcare workers in Wuhan, China. We present information on COVID-19 management relevant to otolaryngologists on the frontlines of this pandemic and provide preliminary guidance based on practices implemented in China and other countries and practical strategies deployed at Stanford University. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; SARS-CoV-2; clinical practice guidelines; evidence-based medicine; infectious disease
PMID:32219846DOI:10.1002/lary.28672
COVID-19 and the otolaryngologist - preliminary evidence-based review.
Vukkadala N[SUP]1[/SUP], Qian ZJ[SUP]1[/SUP], Holsinger FC[SUP]1[/SUP], Patel ZM[SUP]1[/SUP], Rosenthal E[SUP]1[/SUP].
Author information
Abstract
The SARS-CoV-2 virus which causes coronavirus disease 2019 (COVID-19) has rapidly swept across the world since its identification in December 2019. Otolaryngologists are at unique risk due to the close contact with mucus membranes of the upper respiratory tract and have been among the most affected healthcare workers in Wuhan, China. We present information on COVID-19 management relevant to otolaryngologists on the frontlines of this pandemic and provide preliminary guidance based on practices implemented in China and other countries and practical strategies deployed at Stanford University. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; SARS-CoV-2; clinical practice guidelines; evidence-based medicine; infectious disease
PMID:32219846DOI:10.1002/lary.28672